The Innovative Drug Developed by Professor Lu Tao has been Officially Approved by the FDA for Clinical Trials

Source:理学院英文网  Time:2017-12-25  Page Views:12

The Innovative Drug Developed by Professor Lu Tao has been Officially Approved by the FDA for Clinical Trials

2017.10.30


Recently, the innovative small-molecule chemical FN-1501 developed by Professor LU Tao from School of Science has been officially approved by the US Food and Drug Administration (FDA) for clinical trials of leukemia. At the same time, the new drug has been submitted for clinical trial to China's State Food and Drug Administration and was registered for review and approval in August 2017. Recently, the drug will undergo clinical trials in the United States and mainland China.

At present, there is no drug with independent intellectual property rights in China (excluding Hong Kong, Macao, and Taiwan) and the drug with the target of the new drug is marketed. The new drug with the same target will be listed for the first time in the United States in 2017. The project was transferred to Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. with a total consideration of RMB50 million and an after-market sale of RMB100 million. This is a small molecule innovative drug that our school has stepped into the international mainstream research and development field and is the latest achievement made by our school over the years in adhering to innovative drug research.


(Contributor: WANG Duobing   Translator: YUE Wanqing)